Newfeed

SINGAPORE, April 5, 2024 /PRNewswire/ — GSK Singapore announced that the Health Sciences Authority (HSA) has approved a new indication and a new strength for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol ‘FF/UMEC/VI’) for the maintenance treatment of asthma in patie

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: